Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug [11]

American Journal of Hematology

Volumn 82, Issue 6, 2007, Pages 502-503

  Duek, Adrian ^a   Feldberg, Edith ^a   Haran, Michal ^a   Berrebi, Alain ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; MELPHALAN; STEROID;

ADULT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HUMAN; ISRAEL; LETTER; LUNG FIBROSIS; MULTIPLE MYELOMA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; PULMONARY FIBROSIS; PYRAZINES; RECURRENCE; RESPIRATORY INSUFFICIENCY; STEROIDS; TREATMENT FAILURE;

EID: 34249818189     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20891     Document Type: Letter

References (4)

1. Richardson P, Sonneveld P, Schuster MW, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 2005;352:2487-2498.
2. Voortmann J, Giaccone G. Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: A case report. BMC Cancer 2006;6:129.
3. Miyakoshi S, Kami M, Yuji K, et al. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Blood 2006;107: 3492-3494.
4. Boyer JE, Batra RB, Ascensao JL. Severe pulmonary complication after bortezomib treatment for multiple myeloma. Blood 2006;108:1113.